Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma (M032-HSV-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02062827
Recruitment Status : Recruiting
First Posted : February 14, 2014
Last Update Posted : May 12, 2020
Sponsor:
Information provided by (Responsible Party):
James Markert, MD, University of Alabama at Birmingham

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : September 2023